3645 — Medical Net Cashflow Statement
0.000.00%
Last trade - 00:00
- ¥3bn
- ¥3bn
- ¥5bn
- 87
- 43
- 39
- 60
2019 May 31st | 2020 May 31st | 2021 May 31st | 2022 May 31st | 2023 May 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 152 | 104 | 254 | 539 | 251 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 29.7 | 10.8 | 81.4 | -80 | 142 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -179 | -57.1 | 31.5 | -146 | -26.1 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Taxes Payable | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 22.2 | 78.3 | 392 | 343 | 429 |
Capital Expenditures | -23.2 | -8.74 | -13 | -2.17 | -20.6 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -122 | -5.87 | -75 | -353 | -41.7 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Sale of Intangible Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -145 | -14.6 | -88 | -355 | -62.4 |
Financing Cash Flow Items | — | -9.96 | — | 1.05 | 0.239 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -21.2 | -497 | -34 | 282 | -17.9 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -144 | -433 | 273 | 260 | 385 |